Grant to Develop Diagnostic Tool for Non-Small Cell Lung Cancer Awarded to BioMarker Strategies
Lung Cancer, News
BioMarker Strategies was awarded a Phase 1/2 Fast Track Small Business Innovative Research grant from the National Cancer Institute (NCI) to develop a new biomarker test called PathMAP NSCLC. The diagnostic test will guide individualized ... Read more